Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timucin Avsar

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2012
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisTimucin Avsar, Didem Korkmaz, Melih Tütüncü, et al.
RSC Advances|November 2, 2022
Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga <i>Caulerpa cylindracea</i> Sonder in the DardanellesEbru Erol, Muge Didem Orhan, Timucin Avsar, et al.
ACS Chemical Neuroscience|September 9, 2025
Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of RemyelinationMuge Didem Orhan, Lalehan Oktay, Ayşe Irem Cınar, et al.
Molecular Informatics|September 16, 2021
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro StudySerdar Durdagi, Muge Didem Orhan, Busecan Aksoydan, et al.
Plos One|May 6, 2015
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesTimucin Avsar, İlknur Melis Durası, Uğur Uygunoğlu, et al.
Phytochemical Analysis : PCA|September 29, 2021
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC-ESI-MS/MS and their in-silico modelling and in vitro antiviral activity studies against SARS-CoV-2Kubra Dogan, Ebru Erol, Muge Didem Orhan, et al.
Molecular Diagnosis & Therapy|April 11, 2020
Development of a Rapid and Sensitive IDH1/2 Mutation Detection Method for Glial Tumors and a Comparative Mutation Analysis of 236 Glial Tumor SamplesTimucin Avsar, Alihan Sursal, Gizem Turan, et al.
Plos One|June 20, 2023
Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markersElif Everest, Ugur Uygunoglu, Melih Tutuncu, et al.
BMC Rheumatology|July 19, 2023
Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapyFulya Cosan, Ozlem Unay Demirel, Demet Yalcin, et al.
European Journal of Medicinal Chemistry|January 13, 2018
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferationSerdar Durdagi, Busecan Aksoydan, Ismail Erol, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2012
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisTimucin Avsar, Didem Korkmaz, Melih Tütüncü, et al.
RSC Advances|November 2, 2022
Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga <i>Caulerpa cylindracea</i> Sonder in the DardanellesEbru Erol, Muge Didem Orhan, Timucin Avsar, et al.
ACS Chemical Neuroscience|September 9, 2025
Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of RemyelinationMuge Didem Orhan, Lalehan Oktay, Ayşe Irem Cınar, et al.
Molecular Informatics|September 16, 2021
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro StudySerdar Durdagi, Muge Didem Orhan, Busecan Aksoydan, et al.
Plos One|May 6, 2015
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesTimucin Avsar, İlknur Melis Durası, Uğur Uygunoğlu, et al.
Phytochemical Analysis : PCA|September 29, 2021
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC-ESI-MS/MS and their in-silico modelling and in vitro antiviral activity studies against SARS-CoV-2Kubra Dogan, Ebru Erol, Muge Didem Orhan, et al.
Molecular Diagnosis & Therapy|April 11, 2020
Development of a Rapid and Sensitive IDH1/2 Mutation Detection Method for Glial Tumors and a Comparative Mutation Analysis of 236 Glial Tumor SamplesTimucin Avsar, Alihan Sursal, Gizem Turan, et al.
Plos One|June 20, 2023
Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markersElif Everest, Ugur Uygunoglu, Melih Tutuncu, et al.
BMC Rheumatology|July 19, 2023
Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapyFulya Cosan, Ozlem Unay Demirel, Demet Yalcin, et al.
European Journal of Medicinal Chemistry|January 13, 2018
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferationSerdar Durdagi, Busecan Aksoydan, Ismail Erol, et al.
Pageof 4